Kevin Zhu, Mahmoud Nassar, Atulya Aman Khosla, Rohit Singh. "Real-world outcomes with atezolizumab versus durvalumab plus chemotherapy for extensive-stage small cell lung cancer: A TriNetX propensity-matched analysis.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.11145